BRPI0408675A - derivados de talidomida solúveis em água - Google Patents

derivados de talidomida solúveis em água

Info

Publication number
BRPI0408675A
BRPI0408675A BRPI0408675-9A BRPI0408675A BRPI0408675A BR PI0408675 A BRPI0408675 A BR PI0408675A BR PI0408675 A BRPI0408675 A BR PI0408675A BR PI0408675 A BRPI0408675 A BR PI0408675A
Authority
BR
Brazil
Prior art keywords
chr
water soluble
thalidomide derivatives
alkyl
soluble thalidomide
Prior art date
Application number
BRPI0408675-9A
Other languages
English (en)
Inventor
Hesheng Zhang
Original Assignee
Tian Jin Hemay Bio Tech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tian Jin Hemay Bio Tech Co Ltd filed Critical Tian Jin Hemay Bio Tech Co Ltd
Publication of BRPI0408675A publication Critical patent/BRPI0408675A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Artificial Filaments (AREA)

Abstract

"DERIVADOS DE TALIDOMIDA SOLúVEIS EM AGUA". Trata-se de novos derivados de talidomida (I) e suas bases ou sais: em que R representa CHR¬ 1¬NR¬ 2¬R¬ 3¬, CHR¬ 1¬NR¬ 4¬C(O)CHR¬ 5¬NR¬ 2R¬ 3¬ W ou CHR¬ 5¬NR¬ 4¬C(O)W, em que R¬ 1¬, R¬ 4¬ e R¬ 5¬ representam, independentemente um do outro, H, C ~1-4~ alquila, R¬ 2¬ é uma C~ 1-4~ alquila, R¬ 3¬ é uma C~ 1-4~ alquila, ou R¬ 2¬ e R¬ 3¬ representam conjuntamente 1,3-propileno, 1,4-butileno, 1,5-pentileno, 1,6-hexileno, W representa um heterociclo de quatro, cinco, seis, sete ou oito membros, saturado ou insaturado. A invenção também se refere a processos para a sua produção e ao seu uso como um ingrediente farmacêutico ativo.
BRPI0408675-9A 2003-03-27 2004-03-04 derivados de talidomida solúveis em água BRPI0408675A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB031209947A CN100488959C (zh) 2003-03-27 2003-03-27 水溶性的酞胺哌啶酮衍生物
PCT/CN2004/000167 WO2004085422A1 (en) 2003-03-27 2004-03-04 Water-soluble thalidomine derivatives

Publications (1)

Publication Number Publication Date
BRPI0408675A true BRPI0408675A (pt) 2006-03-28

Family

ID=33035142

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0408675-9A BRPI0408675A (pt) 2003-03-27 2004-03-04 derivados de talidomida solúveis em água

Country Status (12)

Country Link
US (1) US7741342B2 (pt)
EP (1) EP1607394B1 (pt)
JP (1) JP4703554B2 (pt)
CN (1) CN100488959C (pt)
AT (1) ATE479675T1 (pt)
AU (1) AU2004224271B2 (pt)
BR (1) BRPI0408675A (pt)
CA (1) CA2519051A1 (pt)
DE (1) DE602004028917D1 (pt)
ES (1) ES2349372T3 (pt)
WO (1) WO2004085422A1 (pt)
ZA (1) ZA200506797B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1389203B8 (en) 2001-02-27 2010-03-10 The Governement of the United States of America, represented by The Secretary Department of Health and Human services Analogs of thalidomide as angiogenesis inhibitors
WO2005016326A2 (en) * 2003-07-11 2005-02-24 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Analogs of thalidomide as potential angiogenesis inhibitors
US8952895B2 (en) 2011-06-03 2015-02-10 Apple Inc. Motion-based device operations
WO2005028436A2 (en) 2003-09-17 2005-03-31 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Thalidomide analogs as tnf-alpha modulators
CN100383139C (zh) * 2005-04-07 2008-04-23 天津和美生物技术有限公司 可抑制细胞释放肿瘤坏死因子的哌啶-2，6-二酮衍生物
EP2358697B1 (en) * 2008-10-29 2015-10-21 Celgene Corporation Isoindoline compounds for use in the treatment of cancer.
US8927725B2 (en) 2011-12-02 2015-01-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Thio compounds
CA3045703C (en) * 2016-11-24 2021-11-02 Tianjin Hemay Bio-Tech Co., Ltd Piperidine-2,6-dione derivatives and ulcerative colitis treating
US20200199097A1 (en) * 2017-08-21 2020-06-25 Nanjing Noratech Pharmaceuticals Co., Ltd Pomalidomide derivative and preparation method therefor
CN111499610A (zh) * 2019-01-31 2020-08-07 南京诺瑞特医药科技有限公司 泊马度胺前体药物盐的多晶型物
CN110028439B (zh) * 2019-04-25 2020-11-13 四川大学 邻苯二甲酰亚胺类衍生物及其制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992018496A1 (de) * 1991-04-17 1992-10-29 Grünenthal GmbH Neue thalidomidderivate, ein verfahren zu deren herstellung sowie die verwendung derselben in arzneimitteln
DE19613976C1 (de) * 1996-04-09 1997-11-20 Gruenenthal Gmbh Thalidomid-Prodrugs mit immunmodulatorischer Wirkung
CN100383139C (zh) * 2005-04-07 2008-04-23 天津和美生物技术有限公司 可抑制细胞释放肿瘤坏死因子的哌啶-2，6-二酮衍生物

Also Published As

Publication number Publication date
JP4703554B2 (ja) 2011-06-15
DE602004028917D1 (de) 2010-10-14
ATE479675T1 (de) 2010-09-15
ES2349372T3 (es) 2010-12-30
JP2006521295A (ja) 2006-09-21
ZA200506797B (en) 2006-05-31
US7741342B2 (en) 2010-06-22
AU2004224271B2 (en) 2010-02-18
CA2519051A1 (en) 2004-10-07
EP1607394A4 (en) 2008-06-25
EP1607394B1 (en) 2010-09-01
AU2004224271A1 (en) 2004-10-07
CN100488959C (zh) 2009-05-20
EP1607394A1 (en) 2005-12-21
WO2004085422A1 (en) 2004-10-07
CN1534035A (zh) 2004-10-06
US20060094730A1 (en) 2006-05-04

Similar Documents

Publication Publication Date Title
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
DE69528005D1 (de) Prolineamid-Derivate
ATE126795T1 (de) Benzopyranderivate und verfahren zu ihrer herstellung.
ATE245152T1 (de) Dioxocyclopentylhydroxamsäure
MXPA02012034A (es) Derivados de tiofeno utiles como agentes anticancerosos.
DE60027015D1 (en) Pseudoerythromycin-derivate
EP0767170A4 (en) Novel 4,6-diarylpyrimidine derivatives and salts thereof
DE69519921D1 (de) Imidazolidin-derivate und ihre verwendung
AR022469A1 (es) Uso de acidos isoxazolcarboxilicos sustituidos y derivados y nuevas sustancias
DE69820248D1 (de) Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben
EP1371640A4 (en) NEW A-LIPONIC ACID DERIVATIVE AND ITS USE
ATE479675T1 (de) Wasserlösliche thalidominderivate
EP1314719A4 (en) Benzoic acid derivatives and medicaments containing them as active ingredients
PT992509E (pt) Novos derivados macrolidos
DE69834500D1 (de) Xanthinderivative zur behandlung von hirnischämie
DE3882895D1 (de) Imid-derivate, ihre herstellung und verwendung.
ATE89739T1 (de) Entzuendungshemmende und/oder antiallergische zusammensetzung, die glutathionderivate enthaelt.
EP1434762A4 (en) 4'-methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor
EP1226819A4 (en) INHIBITORS FOR THE 20-HETE-PRODUCING ENZYME
FI97883B (fi) Menetelmä lääkeaineena käyttökelpoisen glyserolijohdannaisen valmistamiseksi
DK0551844T3 (da) Svovlholdige galdesyrederivater
ES2168119T3 (es) Derivados de quinoxalina para el tratamiento de tinnitus.
ATE420855T1 (de) 2-substituierte vitamin-d-derivate
ATE243219T1 (de) 9a, 11b-dehydro derivative von 9-oxime-3-keto-6-0-methylerythromycin
ATE380028T1 (de) Mittel zur anregung des appetits und mittel zur behandlung von anorexie

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012.